- Patient-relevant endpoints: Determination of tumor stage (staging), treatment response of the lymphoma (“residual disease evaluation”/ “restaging”), detection of relapses and their effect on mortality and morbidity, diagnostic and prognostic accuracy (p

malignant lymphoma

C81, C82, C83, C84, C85